GlobeNewswire 11-06 Ligand Reports Third Quarter 2025 Financial Results and Raises Guidance
GlobeNewswire 11-06 Accipiter Biosciences Emerges from Stealth with $12.7 Million in Seed Financing to Deliver de novo P...
GlobeNewswire 11-06 C4 Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights
GlobeNewswire 11-05 SCYNEXIS Reports Third Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire 11-04 Transgene Provides Business and Financial Update for Q3 2025
GlobeNewswire 11-04 CytomX Therapeutics to Present CX-801 Phase 1 Monotherapy Biomarker Data at the Society for Immunoth...
GlobeNewswire 11-04 Renowned Pharma and Biotech Development Leader, Dr. Andreas Wallnöfer, is named to Optigo Biotherape...
GlobeNewswire 11-04 Aquestive Therapeutics Announces Leadership Expansion to Support Growth
GlobeNewswire 11-04 Ascentage Pharma to Present Data from Two Clinical Studies for Bcl-2 Inhibitor Lisaftoclax, Includin...
GlobeNewswire 11-04 Ascentage Pharma to Present Data from Multiple Studies of Olverembatinib, Including the First Datase...
TeleTrader 11-03 US closes mostly higher after tech giants' deals, data
GlobeNewswire 11-03 Phlow Corp. Congratulates the Commonwealth of Virginia and the Virginia Innovation Partnership Corpo...
GlobeNewswire 11-03 Life Biosciences Appoints Industry Veteran David Guyer, M.D. to Board of Directors
GlobeNewswire 11-03 Kailera Therapeutics Appoints Frank Clyburn to Board of Directors
GlobeNewswire 11-03 Pyxis Oncology Provides Business Update and Reports Third Quarter 2025 Financial Results
GlobeNewswire 10-31 Adagene Announces First Patient Dosed in Randomized Dose Optimization Cohort of the Phase 2 Study of...
GlobeNewswire 10-30 Ligand to Participate in November Investor Conferences
GlobeNewswire 10-30 Evaxion raises $7.2 million, extending cash runway to second half of 2027
TeleTrader 10-30 Merck's Q3 sales rise by 4% to $17.3 billion
GlobeNewswire 10-30 Ascentage Pharma to Participate in Two Upcoming Investor Conferences in November 2025
GlobeNewswire 10-29 OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results
GlobeNewswire 10-29 Immutep Quarterly Activities Report Q1 FY26
GlobeNewswire 10-28 Step Pharma announces the appointment of Dr Karen Smith as Chief Medical Officer
GlobeNewswire 10-27 Neuphoria Therapeutics Adopts Limited-Duration Stockholder Rights Plan to Protect Integrity of Proce...
GlobeNewswire 10-27 Healthcare M&A Activity Increases 7% in Q3:25